TMO

Thermo Fisher Scientific Inc.
$526.23
-6.25 (-1.17%)
Mkt Cap 196.35B
Volume 1,184,766
52W Range 403.36-643.99
Sector Healthcare
Beta 0.87
EPS (TTM) 18.22
P/E Ratio 29.00
Revenue (TTM) 45.20B
Rev Growth (5Y) +6.7%
EPS Growth (5Y) +2.0%
AlphaVal · Fair Value
What we estimate one share is worth
$403.21
Overvalued moderate signal
31.0% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
C+
Stable Earnings Power
60.3 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 44.56B 42.88B 42.86B 44.91B 39.21B 32.22B 25.54B 24.36B 20.92B 18.27B 16.97B 16.89B
Net Income 6.74B 6.33B 6.00B 6.95B 7.72B 6.38B 3.70B 2.94B 2.23B 2.02B 1.98B 1.89B
EPS 17.77 16.58 15.53 17.73 19.61 16.10 9.24 7.31 5.64 5.12 4.96 4.76
Free Cash Flow 6.29B 7.27B 6.93B 6.91B 7.02B 6.82B 4.05B 3.79B 3.50B 2.71B 2.39B 2.19B
FCF / Share 16.74 19.02 17.95 17.63 17.82 17.21 10.12 9.42 8.85 6.87 6.00 5.50
Operating CF 7.82B 8.67B 8.41B 9.15B 9.54B 8.29B 4.97B 4.54B 4.00B 3.16B 2.82B 2.62B
Total Assets 110.34B 97.32B 98.73B 97.15B 95.12B 69.05B 58.38B 56.23B 56.67B 45.91B 40.83B 42.85B
Total Debt 40.85B 32.77B 36.42B 36.07B 36.34B 22.55B 18.49B 18.99B 21.01B 16.63B 12.47B 14.56B
Cash & Equiv 9.86B 4.02B 8.08B 8.52B 4.48B 10.32B 2.40B 2.10B 1.33B 786.00M 452.10M 1.34B
Book Value 53.41B 49.58B 46.73B 43.98B 40.79B 34.51B 29.68B 27.59B 25.41B 21.54B 21.35B 20.55B
Return on Equity 0.13 0.13 0.13 0.16 0.19 0.18 0.12 0.11 0.09 0.09 0.09 0.09
TMO News
Exploring Analyst Estimates for Thermo Fisher (TMO) Q2 Earnings, Beyond Revenue and EPS
Jul 20, 2026 06:16 AM · zacks.com
AIA Group Ltd Cuts Stock Holdings in Thermo Fisher Scientific Inc. $TMO
Jul 19, 2026 01:05 AM · defenseworld.net
Thermo Fisher Set to Report Q2 Earnings: What's in the Cards?
Jul 15, 2026 05:51 AM · zacks.com
TMO Fairly Valued by DCF at $478
Jul 13, 2026 03:30 AM · gurufocus.com
Thermo Fisher Scientific Announces Quarterly Dividend
Jul 09, 2026 01:00 PM · businesswire.com
Thermo Fisher Q2 Preview: Buy Before The Recovery
Jul 09, 2026 07:29 AM · seekingalpha.com
Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches
Jul 07, 2026 04:30 AM · businesswire.com
Arcturus Picks Thermo Fisher To Support Cystic Fibrosis Therapy
Jul 02, 2026 07:32 AM · benzinga.com
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
Jul 01, 2026 04:00 AM · businesswire.com
genedrive shares climb 8% on Thermo Fisher pharmacogenetic testing deal
Jun 29, 2026 12:07 AM · proactiveinvestors.co.uk